-
Mashup Score: 6Multiplicative Adverse Effects of Social Determinants of Health in Lupus Nephritis: A Meta-analysis and Systematic Review | RheumNow - 15 hour(s) ago
A metanalysis shows that social determinants of health adversely impacts patients with lupus nephritis. Lupus nephritis is a significant complication of SLE, often with dramatic increases in morbid and mortal risks. Outcomes are likely to be augmented by social determinants of health, including socio-economic status, and social risk factors.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 19
Positive findings with color Doppler ultrasound were enough to diagnose giant cell arteritis (GCA) accurately without need for confirmation with temporal artery biopsy (TAB), a prospective study indicated.Out of 165 older patients in whom GCA was strongly suspected, 73 (44%) had the telltale “halo” sign on temporal artery ultrasound; and of those, the GCA diagnosis was unchanged when re-examined 2 years later, according to Guillaume Denis, MD, of Centre Hospitalier Rochefort in France, and colleagues.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 6Featured BSR Abstracts (5.2.2024) | RheumNow - 1 day(s) ago
Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2
The Rotterdam study shows that weight-bearing recreational physical activity caused more incident knee osteoarthritis (KOA), but mainly when there was low muscle mass. KOA risk is traditionally linked to either obesity or injury. This study assesses whether muscle mass may influence osteoarthritis risk.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Clinical Rheumatology – Our study was designed to investigate the reasons for starting the conventional disease-modifying anti-rheumatic drugs (DMARDs) and the variables that impact the response to…
Source: link.springer.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 7
Objective To assess the risk of serious infection associated with different targeted therapies for psoriatic arthritis (PsA) in real-world settings. Methods This nationwide cohort study used the administrative healthcare database of the French health insurance scheme linked to the hospital discharge database to identify all adults with PsA who were new users of targeted therapies (adalimumab, etanercept, golimumab, certolizumab pegol, infliximab, secukinumab, ixekizumab, ustekinumab, and tofacitinib) from 1 January 2015 to 30 June 2021. The primary outcome was a serious infection (ie, requiring hospitalisation), in a time-to-event analysis using propensity score-weighted Cox models, with adalimumab as the comparator, estimating weighted HRs (wHRs) and their 95% CIs. Results A total of 12 071 patients were included (mean age 48.7±12.7 years; 6965 (57.7%) women). We identified 367 serious infections (3.0% of patients), with a crude incidence rate of 17.0 per 1000 person-years (95% CI, 15
Source: rmdopen.bmj.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 9Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies - 2 day(s) ago
AbstractObjectives. To assess disease outcomes after 20 and 12 years of patients with rheumatoid (RA) or undifferentiated arthritis (UA), treated-to-target
Source: academic.oup.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 6
AbstractBackground/Aims. Janus kinase inhibitors (JAKi) are effective therapies for rheumatoid arthritis (RA). However, concerns about their safety in cert
Source: academic.oup.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1
Our results suggest that age, chronic comorbidities, and not being fully vaccinated might be greater risk factors for severe COVID-19 outcomes in patients with IMIDs than the use of IMMs or the IMIDs themselves. Overall, there is a need to take age and comorbidities into consideration when developing COVID-19 guidelines for patients with IMIDs. Further research is needed for specific IMIDs (including IMID severity at the time of SARS-CoV-2 infection) and IMMs (considering dosage and timing before a patient’s first COVID-19 infection).
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 30Tuesday Night Rheumatology- Mastering SLE | RheumNow - 2 day(s) ago
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Rethinking Pre-Clinical Disease in Lupus David Karp, MD Biology and Rx of Lupus Flares Michelle Kahlenberg, MD Current/Future Biomarkers in SLE Andrea Fava, MD
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
Multiplicative Adverse Effects of Social Determinants of Health in Lupus Nephritis: A Meta-analysis and Systematic Review https://t.co/Wht67skbG2 https://t.co/D55phMfHGh